Taking the drug osimertinib once a day after surgery reduces chance of patients dying by 51%, trials show
A pill taken once a day cuts the risk of dying from lung cancer by half, according to “thrilling” and “unprecedented” results from a decade-long global study.
Taking the drug osimertinib after surgery dramatically reduced the risk of patients dying by 51%, results presented at the world’s largest cancer conference showed.
More Stories
Sweden warns of heightened risk of Russian sabotage
NHS in England to trial AI tool to predict risk of fatal heart disease
Rise of almost untreatable superbug linked to a common antibiotic